healthcare-policy
(2)
Biotechnology Innovation Organization
The Biotechnology Innovation Organization (BIO) is the world's largest trade association for the biotech industry, representing more than 1,000 companies, research institutions and state and regional bio centers across the United States and 30-plus countries. Founded in 1993 and headquartered in Washington, D.C., BIO lobbies on drug pricing, intellectual property, regulation and biosecurity, and runs the BIO International Convention - the industry's flagship annual dealmaking and networking event. Led since 2024 by President and CEO John F. Crowley, a rare-disease entrepreneur whose own children have Pompe disease, BIO's stated mission is to advance a 'bio revolution' that cures patients, protects the climate and nourishes humanity.
David Goldhill
David Goldhill is the co-founder and CEO of Sesame, a cash-pay online marketplace where patients buy doctor visits, labs, and prescriptions at fixed prices with no insurance in between. A former entertainment executive who ran the Game Show Network for a decade, he turned healthcare critic after his father died of a hospital-acquired infection, wrote the 2009 Atlantic cover story 'How American Health Care Killed My Father' and the book 'Catastrophic Care,' then built the company that tries to fix what he spent years writing about. He chairs the board of the patient-safety nonprofit Leapfrog Group and is a senior fellow at the Manhattan Institute.